LD-2 disclosure · 2nd Quarter - Report
AMGEN, INC.
Income$60Kfee reported
Client
- Name
- AMGEN, INC.
- Description
- biopharmaceutical company
- Location
- District of Columbia · United States of America
Registrant
- Description
- strategic public affairs
- Location
- Buda, Texas, United States of America
Lobbying activities
3 issuesImmigration
Issues related to visas
LobbyistsJEFFREY MILLER · ASHLEY GUNN
Health Issues
Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars
LobbyistsJEFFREY MILLER · ASHLEY GUNN
Medicare/Medicaid
Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
LobbyistsJEFFREY MILLER · ASHLEY GUNN